A company that believes the best way to manage a patient's body temperature is from the inside out rather than the outside in has just received FDA 510(k) clearance for its newest heat exchange catheter. (Medical Device Daily)
The first U.S. patient implanted with a DuraHeart Left Ventricular Assist System (LVAS) from Terumo Heart (Ann Arbor, Michigan) was discharged last week from the University of Michigan Health System (Ann Arbor) 15 days after receiving the device. (Medical Device Daily)
HeartWare (Farmingham, Massachusetts/Sydney, Australia) said that the first U.S. patient has received its HeartWare Left Ventricular Assist System (LVAS) at Washington Hospital Center (WHC; Washington), which marks the start of HeartWare's U.S. bridge-to-transplant clinical trial. Steven Boyce, MD, surgical director of the heart failure program at WHC, performed the surgery. (Medical Device Daily)
A device designed to keep dangerous blood clots from entering a patient's blood stream and possibly causing a stroke, may soon provide atrial fibrillation (AF) patients an alternative to taking problematic blood-thinning drugs. (Medical Device Daily)
Doctors who treat patients for angina shouldn't rush into angioplasty, according to a new report on the subject, because a combination of medicine and lifestyle changes may be just as effective. (Medical Device Daily)
As with any industry where competition is limited and the demand is high, the blood transfusion industry in the U.S. has seen dramatic price hikes in blood screening products in recent years, according to Candace Williams, VP of the diagnostic division at Biotest Diagnostics (Rockaway, New Jersey). (Medical Device Daily)
